These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8445448)
21. Low utilisation of unactivated protein C in a patient with meningococcal septic shock and disseminated intravascular coagulation. Lignell A; Siegbahn A; Stridsberg M; Pauksen K; Gedeborg R; Sjölin J Acta Anaesthesiol Scand; 2003 Aug; 47(7):897-900. PubMed ID: 12859313 [TBL] [Abstract][Full Text] [Related]
22. Use of bone scan in management of patients with peripheral gangrene due to fulminant meningococcemia. Hamdy RC; Babyn PS; Krajbich JI J Pediatr Orthop; 1993; 13(4):447-51. PubMed ID: 8370778 [TBL] [Abstract][Full Text] [Related]
23. Importance of follow-up research in children surviving meningococcal septic shock. Plötz FB Crit Care Med; 2008 Jul; 36(7):2217; author reply 2217-8. PubMed ID: 18594243 [No Abstract] [Full Text] [Related]
24. Meningococcal purpura fulminans: treatment of vascular insufficiency in a 2-yr-old child with lumbar epidural sympathetic blockade. Anderson CT; Berde CB; Sethna NF; Pribaz JJ Anesthesiology; 1989 Sep; 71(3):463-4. PubMed ID: 2774279 [No Abstract] [Full Text] [Related]
25. Skin necrosis after septic shock. García Harana C; Fernández Canedo I; de Troya Martín M Med Clin (Barc); 2019 Feb; 152(3):e17. PubMed ID: 29789143 [No Abstract] [Full Text] [Related]
26. Management of meningococcal infections. Klein NJ; Heyderman RS; Levin M Br J Hosp Med; 1993 Jun 16-Jul 13; 50(1):42-9. PubMed ID: 8364705 [TBL] [Abstract][Full Text] [Related]
27. Parental participation in treatment decisions for pediatric oncology ICU patients. Overbay JD Dimens Crit Care Nurs; 1996; 15(1):16-24. PubMed ID: 8631216 [TBL] [Abstract][Full Text] [Related]
28. Surviving meningococcal septic shock: health consequences and quality of life in children and their parents up to 2 years after pediatric intensive care unit discharge. Buysse CM; Raat H; Hazelzet JA; Hop WC; Maliepaard M; Joosten KF Crit Care Med; 2008 Feb; 36(2):596-602. PubMed ID: 18216608 [TBL] [Abstract][Full Text] [Related]
37. Is activated C3 a premier factor of DIC development in septic shock? Wu QX; Liu ZY; Dang Y; Chen L; Chen HC Prog Clin Biol Res; 1989; 308():271-5. PubMed ID: 2675052 [No Abstract] [Full Text] [Related]
38. Quality of life assessment following amputation for septic shock: a long-term descriptive survey after symmetric peripheral gangrene. Labroca P; Chiesa G; Laroyenne I; Borrini L; Klotz R; Phan Sy Q; Cristina MC; Martinez AB; Bollaert PE; Paysant J; Lemarié J J Crit Care; 2019 Oct; 53():231-235. PubMed ID: 31277050 [TBL] [Abstract][Full Text] [Related]
39. Treatment of thromboembolic complications of fulminant meningococcal septic shock. Mele JA; Linder S; Capozzi A Ann Plast Surg; 1997 Mar; 38(3):283-90. PubMed ID: 9088469 [TBL] [Abstract][Full Text] [Related]
40. Intracellular organisms in peripheral blood in a case of meningococcal septicaemia. Scott MA; Gobert-Jones J Clin Lab Haematol; 1990; 12(4):477-8. PubMed ID: 2127910 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]